Science
Apr 2, 2025, 2:18 PM
Apr 2, 2025, 2:18 PM
Associated Press

Mount Sinai revolutionizes drug discovery with AI investment

Mount Sinai mountain in the Sinai Peninsula of Egypt New York City most populous city in the United States New York state of the United States of America
Highlights
  • The Icahn School of Medicine at Mount Sinai launched a new center focused on utilizing AI for drug discovery.
  • Research at the center will involve designing novel drug-like molecules and predicting drug-target interactions.
  • This initiative positions Mount Sinai as a leader in integrating AI into biomedical research.
Story

In a major development in biomedical sciences, the Icahn School of Medicine at Mount Sinai in New York launched the AI Small Molecule Drug Discovery Center on April 2, 2025. This initiative aims to revolutionize drug development by integrating artificial intelligence with chemistry and biology. The center will focus on three primary areas: creating novel drug-like molecules using generative AI, optimizing existing compounds for better efficacy and safety, and predicting interactions between drugs and targets to find new applications for known medications. Avner Schlessinger, PhD, will lead this center, emphasizing the potential of AI to dramatically speed up drug discovery processes.

Opinions

You've reached the end